These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37146658)

  • 1. Paper I: Heterogeneous use of registry data for participant identification and primary outcome ascertainment is found in registry-based randomized controlled trials: A scoping review.
    Baba A; Tay J; Sammy A; Douglas WA; Goren K; Krause KR; Howie AH; Little J; Oskoui M; Taljaard M; Thombs BD; Potter BK; Butcher NJ; Offringa M
    J Clin Epidemiol; 2023 Jul; 159():289-299. PubMed ID: 37146658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paper II: thematic framework analysis of registry-based randomized controlled trials provided insights for designing trial ready registries.
    Krause KR; Tay J; Douglas WA; Sammy A; Baba A; Goren K; Thombs BD; Howie AH; Oskoui M; Frøbert O; Trakadis Y; Little J; Potter BK; Butcher NJ; Offringa M
    J Clin Epidemiol; 2023 Jul; 159():330-343. PubMed ID: 37146660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Registry-based randomised controlled trials: conduct, advantages and challenges-a systematic review.
    Shiely F; O Shea N; Murphy E; Eustace J
    Trials; 2024 Jun; 25(1):375. PubMed ID: 38863017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining key design elements of registry-based randomised controlled trials: a scoping review.
    Karanatsios B; Prang KH; Verbunt E; Yeung JM; Kelaher M; Gibbs P
    Trials; 2020 Jun; 21(1):552. PubMed ID: 32571382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical registries data quality attributes to support registry-based randomised controlled trials: A scoping review.
    Prang KH; Karanatsios B; Verbunt E; Wong HL; Yeung J; Kelaher M; Gibbs P
    Contemp Clin Trials; 2022 Aug; 119():106843. PubMed ID: 35792338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Nothing to lose and the possibility of gaining": a qualitative study on the feasibility and acceptability of registry-based randomised controlled trials among cancer patients and clinicians.
    Prang KH; Karanatsios B; Zhang A; Verbunt E; Wong HL; Wong V; Gately L; Tran B; Gibbs P; Kelaher M
    Trials; 2023 Feb; 24(1):92. PubMed ID: 36747274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Registry-based randomized controlled trials merged the strength of randomized controlled trails and observational studies and give rise to more pragmatic trials.
    Mathes T; Buehn S; Prengel P; Pieper D
    J Clin Epidemiol; 2018 Jan; 93():120-127. PubMed ID: 28951111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting transparency and completeness in Trials: Paper 2 - reporting of randomised trials using registries was often inadequate and hindered the interpretation of results.
    Mc Cord KA; Imran M; Rice DB; McCall SJ; Kwakkenbos L; Sampson M; Fröbert O; Gale C; Langan SM; Moher D; Relton C; Zwarenstein M; Juszczak E; Thombs BD; Hemkens LG;
    J Clin Epidemiol; 2022 Jan; 141():175-186. PubMed ID: 34525408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No differences were found between effect estimates from conventional and registry-based randomized controlled trials.
    Mathes T; Klaßen P; Pieper D
    J Clin Epidemiol; 2019 Jan; 105():80-91. PubMed ID: 30257186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Registry randomised trials: a methodological perspective.
    Doherty DA; Tong SYC; Reilly J; Shrapnel J; McDonald S; Ahern S; Harris I; Tam CS; Brennan AL; Hodgson C; Wilcox L; Balagurunathan A; Butcher BE; Reid CM
    BMJ Open; 2023 Mar; 13(3):e068057. PubMed ID: 36858472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions.
    Lund LH; Oldgren J; James S
    Curr Heart Fail Rep; 2017 Apr; 14(2):59-70. PubMed ID: 28247180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities and barriers for the use of Australian cancer registries as platforms for randomized clinical trials.
    Yan MK; Adler NR; Heriot N; Shang C; Zalcberg JR; Evans S; Wolfe R; Mar VJ
    Asia Pac J Clin Oncol; 2022 Aug; 18(4):344-352. PubMed ID: 34811922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of protocols and registry entries to published reports for randomised controlled trials.
    Dwan K; Altman DG; Cresswell L; Blundell M; Gamble CL; Williamson PR
    Cochrane Database Syst Rev; 2011 Jan; 2011(1):MR000031. PubMed ID: 21249714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of routinely collected data in a UK cohort of publicly funded randomised clinical trials.
    McKay AJ; Jones AP; Gamble CL; Farmer AJ; Williamson PR
    F1000Res; 2020; 9():323. PubMed ID: 33163157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment effects in randomised trials using routinely collected data for outcome assessment versus traditional trials: meta-research study.
    Mc Cord KA; Ewald H; Agarwal A; Glinz D; Aghlmandi S; Ioannidis JPA; Hemkens LG
    BMJ; 2021 Mar; 372():n450. PubMed ID: 33658187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.